Original-Research: Nynomic AG (von NuWays AG): BUY

Original-Research: Nynomic AG - from NuWays AG

14.08.2025 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

---

Classification of NuWays AG to Nynomic AG

Company Name:	Nynomic AG
ISIN:	DE000A0MSN11
Reason for the research:	Update
Recommendation:	BUY
from:	14.08.2025
Target price:	EUR 24.50
Target price on sight of:	12 months
Last rating change:
Analyst:	Christian Sandherr

Weak Q2 amid restructuring expenses and weak demand; PT down

Q2 revenue of € 21.5m was down roughly 13% yoy (H1: €42.1m, down 11.7% yoy). The weakness was broad-based across segments, driven by continued geopolitical uncertainty, new trade restrictions, and demand softness in multiple end markets. Customers remain defensive, reducing inventories and delaying larger commitments. This shift in ordering behavior (shorter lead times and avoidance of binding long-term orders) directly impacted visibility and capacity planning. Consequently, order backlog at the end of H1 stood at € 43.4m, down 27% YoY from €59.5m. Importantly, management reiterated that no projects have been cancelled but call-offs lowered and new project launches pushed back.

Q2 EBIT came in at € -1.1m (H1: € -2.0m), compared with € 2.6m in Q2 2024 (H1 2024: €4.2m). This deterioration was driven by lower revenues, reduced production utilization, an unfavorable product mix and restructuring expenses of roughly €1.5m recognized in H1 under the NyFIT2025 program.

FY25 forecast adjusted. Management reduced it FY25 guidance from € 105-110m revenue and €8.5-10.0m EBIT to € 100-105m revenue (eNuW old: € 108m) and € 2.0-4.0m EBIT (eNuW old: € 9.1m). The downgrade reflects slower-than-expected order normalization, delayed project awards, and the temporary EBIT drag from restructuring. Despite this, management anticipates a sequential improvement in H2, with Q4 expected to be the strongest quarter of the year, similar to recent years.

Efficiency program "NyFIT2025" formally introduced. Internally launched in late 2024, NyFIT2025 targets € 5-6m in annual cost savings from 2026 onwards (eNuW: € 5m). Measures include workforce adjustments (number of employees was down 5% at the end of H1), optimization of internal processes, and structural consolidation; notably, merging Spectral Engines GmbH into m-u-t GmbH to simplify operations. The majority of the related upfront costs were already booked during H1 (~ € 1.5m). Going forward, management expects enhanced productivity, improved flexibility, and a leaner fixed cost base, better aligning the company to a volatile demand environment.

We are reducing our price target to € 24.5 (old: € 34.5) accounting for the temporary subdued demand situation across key end markets but reiterate our BUY recommendation as the prospects during the mid-term remain bright. Once notable sales volumes return, one should expect an overproportionate impact on margins supported by the current right-sizing of operations.

You can download the research here: nynomic-ag-2025-08-14-previewreview-en-8609c
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: [e-mail]
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

---

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

2183802 14.08.2025 CET/CEST